Detection of circulating anti-MUC1 mucin core protein antibodies in patients with colorectal cancer

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of gastroenterology

• Publication date

  1998-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s005350050096PMID 9658314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.

  1997cited by this paper
• Effect of MUC1 Mucin, an Anti‐adhesion Molecule, on Tumor Cell Growth

  1996cited by this paper
• Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

  1996cited by this paper
• A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid.

  1996cited by this paper
• Circulating antibodies against p53 protein in patients with ovarian carcinoma

  1996cited by this paper
• Human corneal and conjunctival epithelia express MUC1 mucin.

  1995cited by this paper
• Association of Sialyl-Lewisa and Sialyl-Lewisx with MUC-1 Apomucin in a Pancreatic Cancer Cell Line

  1995cited by this paper
• Human corneal and conjunctival epithelia express MUC1 mucin

  1995cited by this paper
• Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin ina pancreatic cancer cell line.

  1995cited by this paper
• Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

  1994cited by this paper
• The relationship between serum p53 autoantibodies and characteristics of human breast cancer.

  1994cited by this paper
• Expression of Sulfated Carbohydrate Chains Detected by Monoclonal Antibody 91.9H in Human Gastric Cancer Tissues

  1994cited by this paper
• N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.

  1994cited by this paper
• Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.

  1994cited by this paper
• Cellular mucins: targets for immunotherapy.

  1994cited by this paper
• Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction.

  1993cited by this paper
• Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis.

  1993cited by this paper
• Analysis of the anti-p53 antibody response in cancer patients.

  1993cited by this paper
• Human B-cell immune response to the polymorphic epithelial mucin.

  1993cited by this paper
• Heterogeneity of mucin gene expression in normal and neoplastic tissues.

  1993cited by this paper
• A fucose residue can mask the muc‐1 epitopes in normal and cancerous gastric mucosae

  1993cited by this paper
• Perineurioma: An Uncommon Soft Tissue Neoplasm Distinct From Localized Hypertrophic Neuropathy and Neurofibroma

  1992cited by this paper
• The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot.

  1992cited by this paper
• Mucin genes and the proteins they encode: structure, diversity, and regulation.

  1992cited by this paper
• Presence of circulating anti‐c‐myb oncogene product antibodies in human sera

  1991cited by this paper
• Oncofetal expression of the human intestinal mucin glycoprotein antigens in gastrointestinal epithelium defined by monoclonal antibodies

  1991cited by this paper
• Recognition of the Polypeptide Core of Mucin by Monoclonal Antibody MUSE11 against an Adenocarcinoma‐associated Antigen

  1990cited by this paper
• Circulating antibodies against c‐MYC oncogene product in sera of colorectal cancer patients

  1990cited by this paper
• DF3 antigen, a human epithelial cell mucin, inhibits adhesion of eosinophils to antibody-coated targets.

  1990cited by this paper
• Cloning and sequencing of a human pancreatic tumor mucin cDNA.

  1990cited by this paper
• Immunohistological and immunochemical characterization of a novel pancreatic cancer-associated antigen MUSE11.

  1989cited by this paper
• Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms.

  1984cited by this paper
• Human lymphoid cells express epithelial membrane antigen: implications for diagnosis of human neoplasms

  1984cited by this paper
• IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.

  1982cited by this paper
• IgG 2 a monoclonal antibodies inhibit human tumor growth through interaction with effector cells ( macrophages / cytotoxicity / nude mice )

  year unknowncited by this paper

• Variables affecting CA15.3 tumor antigen expression and antibodies against it in female National Health and Nutritional Survey (NHANES) participants.

  2024cites this paper
• Incessant ovulation: a review of its importance in predicting cancer risk

  2023cites this paper
• Anti‐p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta‐analysis

  2020cites this paper
• Current View on Autoimmune Gastritis

  2019cites this paper
• Mucin Expression in Colorectal Cancer (CRC)

  2019cites this paper
• Autoantibodies as biomarkers for colorectal cancer: A systematic review, meta-analysis, and bioinformatics analysis

  2019cites this paper
• Autoimmunity and Gastric Cancer

  2018cites this paper
• Binding of circulating anti-MUC1 antibody and serum MUC1 antigen in stage IV breast cancer.

  2017cites this paper
• Systematic review: Serum autoantibodies in the early detection of gastric cancer

  2015cites this paper
• MUC1 Predicts Colorectal Cancer Metastasis: A Systematic Review and Meta-Analysis of Case Controlled Studies

  2015cites this paper
• The potential role of immunotherapy to treat colorectal cancer

  2015cites this paper
• Developing hyperpolarized silicon particles for advanced biomedical imaging applications

  2015cites this paper
• Development of Silicon-Coated Superparamagnetic Iron Oxide Nanoparticles for Targeted Molecular Imaging and Hyperthermic Therapy of Prostate Cancer

  2015cites this paper
• Detection of Cancer Biomarkers on Biosensor Surfaces

  2014cites this paper
• Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.

  2014cites this paper
• EGF-R, and de2 Δ Receptor (EGF-RvIII, to Mutated Epidermal Growth Factor Immune Responses of Breast Cancer Patients

  2013cites this paper
• MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

  2012cites this paper
• Correlation between auto-antibodies to survivin and MUC1 variable number tandem repeats in colorectal cancer.

  2012influential citation
• Natural and Induced Humoral Responses to MUC1

  2011cites this paper
• Immunogénicite de la mort cellulaire induite par les chimiothérapies anti-cancéreuses

  2011cites this paper
• Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies.

  2011cites this paper
• High-sensitivity detection of carbohydrate antigen 15-3 using a gold/zinc oxide thin film surface plasmon resonance-based biosensor.

  2010cites this paper
• Prognostic and Diagnostic Value of Spontaneous Tumor-Related Antibodies

  2010cites this paper
• Detection of Circulating Anti-Mucin 1 (MUC1) Antibodies in Breast Tumor Patients by Indirect Enzyme-Linked Immunosorbent Assay Using a Recombinant MUC1 Protein Containing Six Tandem Repeats and Expressed in Escherichia coli

  2010cites this paper
• MUC 1 Peptide Vaccination in Patients with Advanced Pancreas or Biliary Tract Cancer

  2009cites this paper
• Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer.

  2009cites this paper
• A systematic review of humoral immune responses against tumor antigens

  2009cites this paper
• Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti‐MUC1 antibody immune selection

  2008cites this paper
• Antibodies as Predictors of Complex Autoimmune Diseases

  2008cites this paper
• Antibodies as predictors of autoimmune diseases and cancer.

  2008cites this paper
• Synthesis and antibody recognition of synthetic antigens from MUC1

  2008cites this paper
• Relação entre a expressão da MUC1 e os estadiamentos TNM e Astler-Coller no câncer colorretal

  2008cites this paper
• Does the Presence of Circulating Tumor Cells in the Venous Drainage of Curative Colorectal Cancer Resections Determine Prognosis? A Meta-Analysis

  2008cites this paper
• Modulation of protective T cell immunity by complement inhibitor expression on tumor cells.

  2008cites this paper
• The clinical significance of autoantibodies in gastrointestinal malignancies: an overview

  2007influential citation
• High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC).

  2007cites this paper
• Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma

  2006cites this paper
• Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patients

  2006cites this paper
• Chapter 5 Local therapy of colorectal liver metastases and formation of antibodies

  2005cites this paper
• Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen

  2005cites this paper
• MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancer.

  2005cites this paper
• Immune Responses of Breast Cancer Patients to Mutated Epidermal Growth Factor Receptor (EGF-RvIII, ΔEGF-R, and de2–7 EGF-R)1

  2004cites this paper
• Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1)

  2004cites this paper
• MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology

  2004cites this paper
• EGF-R ) 7 − EGFR , and de 2 ∆ Receptor ( EGF-RvIII , to Mutated Epidermal Growth Factor Immune Responses of Breast Cancer Patients and Dorothee Herlyn

  2004cites this paper
• MUC1 immunobiology: from discovery to clinical applications.

  2004cites this paper
• Inhibition of a complement regulator in vivo enhances antibody therapy in a model of mammary adenocarcinoma

  2004cites this paper
• Mucins in gastrointestinal cancers.

  2003cites this paper
• Recombinant CD63/ME491/Neuroglandular/NKI/C-3 Antigen Inhibits Growth of Established Tumors in Transgenic Mice 1

  2003cites this paper
• Immunology and immunotherapy of colorectal cancer.

  2003cites this paper
• MHC-UNRESTRICTED MUC1-SPECIFIC T CELL RECEPTOR FOR CANCER IMMUNOTHERAPY/GENE THERAPY

  2003cites this paper
• An anti-MUC1-antibody–interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells

  2003cites this paper
• Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.

  2003cites this paper
• Circulating anti‐MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer

  2003cites this paper
• MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses.

  2002cites this paper
• ANTIBODY-DEPENDEN TCELL-MEDIATE DCYTOTOXICIT YCA NB EINDUCED B YMUC 1PEPTID EVACCINATIO NO FBREAS TCANCE RPATIENTS

  2001cites this paper
• Antibody‐dependent cell‐mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients

  2001cites this paper
• Epitope-dependent differential immunoreactivities of anti-MUC1 monoclonal antibodies in human carcinomas.

  2001cites this paper
• Mucins and Immune Reactions to Mucins in Ulcerative Colitis

  2001cites this paper
• in patients with multiple myeloma Elevated soluble MUC 1 levels and decreased anti-MUC 1 antibody levels

  2000cites this paper
• Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia.

  2000cites this paper
• Elevated soluble MUC 1 levels and decreased anti-MUC 1 antibody levels in patients with multiple myeloma

  2000cites this paper
• Human MUC1 Mucin: A Multifaceted Glycoprotein

  2000cites this paper
• Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma.

  2000cites this paper
• Current perspectives on immunotherapy for colorectal cancer.

  2000cites this paper
• Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.

  2000cites this paper
• Special Section:Future Trendsin Vaccination: Advances in cancer vaccine development

  1999cites this paper
• Advances in cancer vaccine development.

  1999cites this paper
• MUC1-speci®c anti-tumor responses: molecular requirements for CD4-mediated responses

  year unknowncites this paper